BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FIRST QUARTER 2022

/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.026 billion during the first quarter of 2022, growing 10.0 percent on a...

Related Keywords

China ,Boston ,Massachusetts ,United States ,Canada ,America ,Lauren Tengler ,Mike Mahoney ,Kate Haranis ,Boston Scientific Corporation ,Twitter ,Baylis Medical Company Inc ,National Cardiovascular Data ,Facebook ,European Heart Rhythm Association ,Drug Administration ,Boston Scientific ,Pelvic Health ,Specialty Pharmaceuticals ,Exchange Commission ,Prnewswire Boston Scientific Corporation ,Securities Exchange ,National Medical Products Administration ,Health Canada ,Scientific Corporation ,Middle East ,Left Atrial Appendage Closure Device ,Registry Left Atrial Appendage Occlusion ,Cryoablation System ,Fibered Coil ,Image Guided Programming Software ,Deep Brain Stimulation ,Neural Navigator ,Water Vapor ,Elite Single Use Digital Flexible Ureteroscope ,Lithovue Elite System ,Senior Notes ,Emerging Markets ,Medical Devices ,Rhythm Management ,Interventional Cardiology ,Medical Device ,Full Year ,Second Quarter ,Securities Act ,Securities Exchange Act ,Annual Report ,Quarterly Reports ,Months Ended March ,Mandatory Convertible Preferred Stock ,Estimated Annual Effective Tax Rate ,Financial Condition ,Quarterly Report ,